Ciprofloxacin

Description

1. Product Overview

Ciprofloxacin is a synthetic fluoroquinolone antibiotic active against Gram-negative and Gram-positive bacteria. It is primarily used in the manufacture of oral and intravenous human pharmaceuticals, as well as veterinary medicines for livestock and companion animals. The key value proposition is its proven clinical efficacy, stability in formulation, and compliance with international pharmacopoeia standards (USP, EP, BP). Strategically, it remains essential for treating resistant infections, making it a critical inventory item for pharmaceutical supply chains worldwide.

2. Key Specifications & Technical Characteristics

• Chemical composition: Ciprofloxacin (as base or hydrochloride salt), fluoroquinolone class

• Purity level: ≥98.5% to 99.5% (depending on pharmacopoeia grade: USP/EP/BP)

• Physical characteristics: White to pale yellow crystalline powder, odorless, slightly hygroscopic

• Particle size: Customizable (typical D90: <50 µm for direct compression or injectables)

• Bulk density: 0.5–0.7 g/cm³ (typical for API processing)

• Packaging options: 25 kg fiber drums, double LDPE liner; or 50 kg multi-ply kraft bags with liner

• Shelf life: 36 months from date of manufacture when stored in original sealed container at controlled room temperature (15–25°C)

3. Core Industrial Applications

• Primary industry: Human pharmaceutical manufacturing (tablets, capsules, IV solutions, ophthalmic drops)

• Secondary industry: Veterinary pharmaceutical production (treating respiratory and urinary infections in poultry, cattle, swine)

• Operational use cases: Formulation of generic ciprofloxacin 250/500/750 mg tablets; hospital sterile injectable preparations

• Performance advantage over alternatives: Broader spectrum than nalidixic acid; more stable in finished dosage forms than cefalexin in tropical climates

• Efficiency/cost benefit: High yield in synthesis reduces API cost per dose; low impurity profile minimizes rejection rates in final QC testing

4. Competitive Advantages

• Quality consistency: Every batch certified via HPLC, loss on drying, and residual solvent analysis; retains third-party lab verification option

• Supply reliability: Dual manufacturing lines with 50 MT/month capacity; buffer stock held in regional warehouses (Asia, EU, MENA)

• Logistics capability: Door-to-door refrigerated or ambient container shipping; full trackable documentation for customs clearance

• Price competitiveness: Direct-from-manufacturer pricing eliminates trader markup; volume discounts applied at ≥10 MT

• Sustainability: Solvent recovery systems reduce manufacturing carbon footprint by 18%; compliant with REACH and RoHS for waste handling

• Technical support: Full BSE/TSE, DMF Type II available upon NDA; stability study data provided for registration in emerging markets

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): 20 MT (bulk)

• Loading capacity: 20 MT per 20-foot container (standard: 20 pallets of 1,000 kg net each)